Related Experiment Videos
Beneficial effect of peptides from microalgae on anticancer
1Marine Bioprocess Research Center, Pukyong National University, Busan 608-737, Republic of Korea.
Current Protein & Peptide Science
|July 5, 2013
Summary
Marine microalgae peptides exhibit anticancer properties, including antiproliferative and antioxidant effects. These bioactive peptides show potential for cancer prevention, treatment, and anticancer drug development.
Area of Science:
- Marine biotechnology
- Natural product chemistry
- Cancer research
Background:
- Marine organisms, including microalgae, are rich sources of bioactive compounds.
- Peptides from marine sources possess diverse biological activities like antiproliferative and antioxidant effects.
- Protein hydrolysates from marine by-products yield bioactive peptides with therapeutic potential.
Purpose of the Study:
- To review the anticancer activities of peptides derived from microalgae.
- To highlight the potential of marine peptides in cancer prevention and treatment.
- To explore their use as molecular models in anticancer drug discovery.
Main Methods:
- Isolation and purification of bioactive peptides from marine microalgae.
- Enzymatic digestion of marine by-products to generate protein hydrolysates.
- Evaluation of peptide bioactivity, including antioxidant and cytotoxic effects on cancer cell lines (e.g., HepG2, HeLa, AGS, MCF-7).
Main Results:
- Marine peptides demonstrate significant antiproliferative, antioxidant, and antimicrotubule activities.
- Purified peptides show cytotoxic effects against various human cancer cell lines.
- Unusual amino acid residues in these peptides contribute to their unique properties.
Conclusions:
- Marine microalgae-derived peptides hold considerable promise for cancer therapy and prevention.
- These peptides can serve as valuable molecular scaffolds for developing novel anticancer drugs.
- Further research into marine bioactive peptides can unlock new avenues in oncology.
Related Concept Videos
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...